Dato-DXd: Translating Mechanism of Action into Clinical Benefit for Patients with Breast & Lung Cancer
Time: 9:00 am
day: Scientific Program Day One AM
Details:
- Overview of Dato-DXd mechanism of action and the DXd ADC platform
- Dato-DXd in breast cancer: TB01 registrational dataset and overview of the pivotal trial program in TNBC
- Dato-DXd in NSCLC: Efficacy/safety of Dato-DXd in EGFRm NSCLC supporting filing and overview of the pivotal trial program in NSCLC
